ATXN3 and cancer: Our findings are further supported by the fact that ATX3 inactivation selectively affects the NHEJ repair pathway, but not the HR repair pathway, and that IR‐exposed HR‐deficient, but not NHEJ‐deficient, cancer cells are hypersensitive to ATX3 inactivation.